Fig. 2From: Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVERUse of SGLT2 inhibitors or GLP-1 receptor agonists by patient factors according to the hierarchical logistic regression modelBack to article page